SCHEMBL7262113

SCHEMBL7262113

CN1C2CN(S(=O)(=O)c3ccccc3)CC(=O)N2CC12CCN(c1ccncc1)CC2

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.53
CYP2C9 P11712 10/20 0.53
CYP2C19 P33261 9/20 0.53
CYP1A2 P05177 9/20 0.53
CYP2D6 P10635 7/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
HIF1A Q16665 2/20 0.53
MAPK1 P28482 1/20 0.50
TSHR P16473 8/20 0.48
F10 P00742 1/20 0.44
LSS P48449 1/20 0.43
ALDH1A1 P00352 7/20 0.42
USP2 O75604 6/20 0.42
HSD17B10 Q99714 2/20 0.40
CHRM1 P11229 2/20 0.39
HPGD P15428 1/20 0.38
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
HTR7 P34969 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257470 0.91 F10 (0.45) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6078436 0.84 F10 (0.65) F10CHRM1
SCHEMBL6078483 0.78 F10 (0.50) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6079146 0.78 F10 (0.48) F10
SCHEMBL7257479 0.78 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7257384 0.78 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6078771 0.77 F10 (0.41) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6079558 0.75 ITGB3 (0.44) CYP2C9CYP2D6SMN1; SMN2HIF1AMAPK1
SCHEMBL6079405 0.72 CYP2C9 (0.38) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7258000 0.70 F10 (0.48) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346994-A1 CHOLESTEROL BIOSYNTHESIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT TRICYCLIC SPIRO COMPOUNDS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP claimed
EP-1346994-A1 CHOLESTEROL BIOSYNTHESIS INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT TRICYCLIC SPIRO COMPOUNDS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed